465 related articles for article (PubMed ID: 25749931)
1. Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
Maeda Y; Shinohara T; Nagatsu A; Futakawa N; Hamada T
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S242-8. PubMed ID: 25749931
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases.
Kawamura J; Yazawa T; Sumida K; Kida Y; Ogawa R; Tani M; Kawasoe J; Yamamoto M; Harada H; Yamamoto H; Zaima M
World J Surg Oncol; 2016 Feb; 14():56. PubMed ID: 26911142
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
[TBL] [Abstract][Full Text] [Related]
5. Conversion chemotherapy followed by hepatic resection in colorectal cancer with initially unresectable liver-limited metastases.
Galizia G; De Vita F; Lieto E; Zamboli A; Morgillo F; Castellano P; Mabilia A; Auricchio A; Renda A; Ciardiello F; Orditura M
Oncol Rep; 2013 Dec; 30(6):2992-8. PubMed ID: 24126855
[TBL] [Abstract][Full Text] [Related]
6. Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution.
Ammori JB; Kemeny NE; Fong Y; Cercek A; Dematteo RP; Allen PJ; Kingham TP; Gonen M; Paty PB; Jarnagin WR; D'Angelica MI
Ann Surg Oncol; 2013 Sep; 20(9):2901-7. PubMed ID: 23771246
[TBL] [Abstract][Full Text] [Related]
7. Long-term characteristics of 5-year survivors after liver resection for colorectal metastases.
Tanaka K; Shimada H; Ueda M; Matsuo K; Endo I; Togo S
Ann Surg Oncol; 2007 Apr; 14(4):1336-46. PubMed ID: 17235718
[TBL] [Abstract][Full Text] [Related]
8. Survival after hepatic resection in metastatic colorectal cancer: a population-based study.
Cummings LC; Payes JD; Cooper GS
Cancer; 2007 Feb; 109(4):718-26. PubMed ID: 17238180
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and treatment of colorectal liver metastases - workflow].
Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of hepatectomy after hepatic arterial infusion chemotherapy for initially unresectable hepatic colorectal metastases.
Fujimoto Y; Akasu T; Yamamoto S; Fujita S; Moriya Y
J Gastrointest Surg; 2009 Sep; 13(9):1643-50. PubMed ID: 19582514
[TBL] [Abstract][Full Text] [Related]
11. Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases.
Yan TD; Padang R; Morris DL
J Am Coll Surg; 2006 Jan; 202(1):100-11. PubMed ID: 16377503
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of the liver-first approach for patients with initially unresectable and not optimally resectable synchronous colorectal liver metastases.
Okuno M; Hatano E; Kasai Y; Nishio T; Seo S; Taura K; Yasuchika K; Nitta T; Mori A; Okajima H; Kaido T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
Surg Today; 2016 Jun; 46(6):721-8. PubMed ID: 26315324
[TBL] [Abstract][Full Text] [Related]
14. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases.
Cauchy F; Aussilhou B; Dokmak S; Fuks D; Gaujoux S; Farges O; Faivre S; Lepillé D; Belghiti J
Ann Surg; 2012 Nov; 256(5):746-52; discussion 752-4. PubMed ID: 23095618
[TBL] [Abstract][Full Text] [Related]
15. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.
Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H
World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502
[TBL] [Abstract][Full Text] [Related]
16. Is hepatic resection for multiple liver metastases from colorectal carcinoma acceptable treatment?
Tanaka K; Shimada H; Togo S; Ota M; Yamagichi S; Ike H
Hepatogastroenterology; 2001; 48(39):803-7. PubMed ID: 11462928
[TBL] [Abstract][Full Text] [Related]
17. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study).
Hatano E; Okuno M; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):634-45. PubMed ID: 25926024
[TBL] [Abstract][Full Text] [Related]
18. Repeat hepatectomy for recurrent hepatic metastases from colorectal cancer.
Yamada H; Katoh H; Kondo S; Okushiba S; Morikawa T
Hepatogastroenterology; 2001; 48(39):828-30. PubMed ID: 11462933
[TBL] [Abstract][Full Text] [Related]
19. A multicenter phase II trial of mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808).
Uetake H; Yasuno M; Ishiguro M; Kameoka S; Shimada Y; Takahashi K; Watanabe T; Muro K; Baba H; Yamamoto J; Mizunuma N; Tamagawa H; Mochizuki I; Kinugasa Y; Kikuchi T; Sugihara K
Ann Surg Oncol; 2015 Mar; 22(3):908-15. PubMed ID: 25465375
[TBL] [Abstract][Full Text] [Related]
20. Hepatectomy for liver metastases in non-colorectal, non-neuroendocrine cancer patients. The survival benefit in primary unresectable cases.
Maeda Y; Shinohara T; Katayama T; Futakawa N; Hamada T
Int J Surg; 2015 Oct; 22():136-42. PubMed ID: 26277530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
